Correlation Between RLX TECH and Compugroup Medical

Can any of the company-specific risk be diversified away by investing in both RLX TECH and Compugroup Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RLX TECH and Compugroup Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between RLX TECH SPADR1 and Compugroup Medical SE, you can compare the effects of market volatilities on RLX TECH and Compugroup Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RLX TECH with a short position of Compugroup Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of RLX TECH and Compugroup Medical.

Diversification Opportunities for RLX TECH and Compugroup Medical

0.41

Correlation Coefficient

RLX TECH  Compugroup Medical

Very weak diversification

The 3 months correlation between RLX and Compugroup is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding RLX TECH SPADR1 and Compugroup Medical SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compugroup Medical and RLX TECH is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RLX TECH SPADR1 are associated (or correlated) with Compugroup Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compugroup Medical has no effect on the direction of RLX TECH i.e., RLX TECH and Compugroup Medical go up and down completely randomly.

Pair Corralation between RLX TECH and Compugroup Medical

Assuming the 90 days horizon RLX TECH SPADR1 is expected to generate 1.34 times more return on investment than Compugroup Medical. However, RLX TECH is 1.34 times more volatile than Compugroup Medical SE. It trades about 0.09 of its potential returns per unit of risk. Compugroup Medical SE is currently generating about 0.06 per unit of risk. If you would invest  148.00  in RLX TECH SPADR1 on September 4, 2024 and sell it today you would earn a total of  28.00  from holding RLX TECH SPADR1 or generate 18.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.46%
Values	Daily Returns

RLX TECH SPADR1  vs.  Compugroup Medical SE

RLX TECH SPADR1

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in RLX TECH SPADR1 are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, RLX TECH reported solid returns over the last few months and may actually be approaching a breakup point.

Compugroup Medical

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Compugroup Medical SE are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Compugroup Medical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with RLX TECH and Compugroup Medical

The main advantage of trading using opposite RLX TECH and Compugroup Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RLX TECH position performs unexpectedly, Compugroup Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugroup Medical will offset losses from the drop in Compugroup Medical's long position.

The idea behind RLX TECH SPADR1 and Compugroup Medical SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.